Formulation and evaluation of solid dispersions of an anthelmintic drug for enhancement of dissolution rate

Authors

  • Patil Anasuya Department of Pharmaceutics, KLE University’s College of Pharmacy, Bengaluru, Karnataka, India- 560010.
  • Sourabh Kumar Department of Pharmaceutics, KLE University’s College of Pharmacy, Bengaluru, Karnataka, India- 560010

Abstract

The purpose of present research work was to improve dissolution rate of Mebendazole which belongs to BCS II drug by enhancing its aqueous solubility using different hydrophilic carriers like PEG 6000 and Poloxamer 338. The various solid dispersion formulations were prepared by employing fusion and solvent evaporation method using different carriers. Further solid dispersion formulations were subjected to different in-vitro evaluation tests for solubility, drug content uniformity, drug-polymer interaction, DSC study and in-vitro drug release study. The results of drug content uniformity showed uniform dispersion of Mebendazole in solid dispersion formulations. To know the dispersion of drug in polymers used DSC study was carried out. The endothermic peak at 254.43°C due to Mebendazole was partially and completely disappeared in solid dispersion formulation indicating that drug was completely dispersed in formulations. In-vitro drug release showed 80.35% in 60minutes for the best solid dispersion formulation F3 (Mebendazole and Poloxamer 338 ratio 1:2) which was prepared using fusion method

Keywords:

Solubility enhancement technique, solid dispersion, poorly water-soluble drug, Anthelmintics

Downloads

Download data is not yet available.

Published

05-07-2017
Statistics
39 Views | 28 Downloads

How to Cite

Patil Anasuya, and Sourabh Kumar. “Formulation and Evaluation of Solid Dispersions of an Anthelmintic Drug for Enhancement of Dissolution Rate”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 4, no. 3, July 2017, pp. 71-74, https://jipbs.com/index.php/journal/article/view/239.

Issue

Section

Research Article